For Javier Ariel, a Rowan University faculty member, the journey to becoming a U.S. citizen has been more than five years in the making. With his wife and family seated in the packed jury room at the Cumberland County Courthouse in Bridgeton on Thursday, Ariel took the Naturalization Oath of Allegiance — one of the final steps on his journey to becoming an American citizen. Stories by Nyah Marshall Therapist who defrauded schools can no longer treat N.J. students, state says Water main break behind N.J. high school delays classes, closes roads Weed activist sues N.J. mayor, claims he was harassed over ‘City Government Sucks’ signNone
Ruud van Nistelrooy admits he was “hurt” at having to leave Manchester United last month. Van Nistelrooy returned to Old Trafford as Erik ten Hag’s assistant in the summer and had a four-game interim spell in charge following his compatriot’s sacking in October. He left the club in the wake of Ruben Amorim’s appointment but was only out of work for two weeks after being appointed Leicester’s new manager on a deal until 2027. The 48-year-old had a glittering playing career with United and was disappointed his return had to end so soon. “The moment I took over the interim job what I said was I’m here to help United and to stay to help United, and I meant it,” he said. “So I was disappointed, yeah, very much so, and it hurt I had to leave. “The only job I would take as an assistant was at United because of the bond that I have with the people in the club and the fans. “But in the end I got my head around it because I also understand the new manager. I’m in football long enough, and I’ve managed myself, that you can think of a situation, me being there, I understand. “I spoke to Ruben about it, fair enough to him, the conversation was grateful, man to man, person to person, manager to manager, and that helped a lot to move on and straightaway get into talks with new possibilities which of course lifted my spirits.” The Dutchman takes on a difficult job at the King Power Stadium as he is tasked with keeping Leicester in the Premier League. He inherits an influential dressing room, which has seen a number of managers come and go over the last few years. Ruud's here for his first press conference as our Manager 😃 — Leicester City (@LCFC) Van Nistelrooy revealed he has done his due diligence and also let the players know as well. “It’s the only way you can work. It’s mutual respect. I also mentioned to the players yesterday that I looked at the squad and started to make phone calls about players, because in football everyone knows everyone,” he said. “With two or three phone calls you hear stories about 20 players and for me it was important that you hear there are good characters there. That’s important, that there are good people there. “I look at the players how they play. I obviously don’t know them but I got general information and the individuals that they are a good bunch of people. That was important for me to get in.”
NEW YORK (AP) — After acquiring Juan Soto for a one-year rental and failing to keep him as a free agent, the New York Yankees are taking the same chance with Devin Williams. New York acquired the All-Star closer from the Milwaukee Brewers for left-hander Nestor Cortes and infield prospect Caleb Durbin on Friday. The Yankees will send $2 million to the Brewers as part of the trade. “He's a year away from free agency but someone that we’ve tried to acquire for a number of years,” Yankees general manager Brian Cashman said. “I’m sure we weren’t the only bidders here in the end.” A 30-year-old right-hander, Williams is eligible for free agency after the 2025 season. He was diagnosed during spring training with two stress fractures in his back and didn’t make his season debut until July 28 . “Certainly not trying to downplay the impact the Devin had, but we feel like we still have a good amount of strength there with our bullpen,” Brewers general manager Matt Arnold said. Williams was 14 for 15 in save chances with a 1.25 ERA, striking out 38 and walking 11 among 88 batters over 21 2/3 innings. His fastball averaged 94.7 mph and he threw it on 53.5% of his pitches, mixing in 45% changeups — known as the “Airbender” — and around 1.5% cutters. William's 43.2% strikeout percentage was the highest in the major leagues among pitchers with at least 20 innings. “Certainly doesn’t seem to be afraid,” Cashman said. “You can’t do that job if you’re afraid of the big stage.” An All-Star in 2022 and 2023, Williams was a second-round pick in the 2013 amateur draft. He is 27-10 with a 1.83 ERA and 68 saves in 78 chances over six seasons, striking out 375 and walking 112 in 235 2/3 innings over 241 games. Milwaukee declined a $10.5 million club option in favor of a $250,000 buyout last month, making Williams eligible for arbitration. Williams joins a bullpen that includes Luke Weaver, who took over as closer from Clay Holmes in September, Jake Cousins and Ian Hamilton. The Yankees don’t have a left-handed reliever on their 40-man roster. “If you have right handers that can neutralize lefties, that’s a benefit. It limits your desperation for immediately a left on left,” Cashman said. Cortes, who turned 30 on Tuesday, was an All-Star in 2022 when he went 12-4 with a career-best 2.44 ERA in 28 starts. He made just one start after May 30 in 2023 because of a strained left rotator cuff and was sidelined late in the 2024 season by a flexor strain in his left elbow. He returned for the World Series against the Los Angeles Dodgers and entered in the 10th inning of the opener, retiring Shohei Ohtani on a foulout with his first pitch and giving up a game-ending grand slam to Freddie Freeman on his second. "He’s had a fully healthy offseason," Arnold said. “We expect him to come into camp ready to go as normal.” Known for his many deliveries, Cortes is 33-21 with a 3.80 ERA in 86 starts and 49 relief appearances over seven seasons. He is eligible for arbitration and also can become a free agent after next season. “He brings a real stability, I think, to our rotation,” Arnold said. “Somebody that's been a major piece of a really good championship-caliber team in the New York Yankees, I think will fit us very well, especially after the loss of Willy Adames .” New York had an excess of starters after reaching a $218 million, eight-year agreement with left-hander Max Fried that is pending. The rotation also is projected to include ace Gerrit Cole, Carlos Rodón, Luis Gil and Clarke Schmidt, with Marcus Stroman also available. Durbin, who turns 25 in February, hit .287 with 10 homers, 60 RBIs and 29 stolen bases this year at Triple-A Scranton/Wilkes-Barre. “We just felt it was harder to acquire someone at the level of Devin Williams than it would be to try to figure out the infield circumstances,” Cashman said. Durbin was with the big league team last spring training “I think he’s a stud,” Yankees manager Aaron Boone said last month. “Great bat-to-ball, elite ability on the bases as a base stealer, good defender in the middle of the diamond, second base. He’s really started over the last year-plus to create some position flexibility, too. He’s played some short, he’s played some third. We introduced him to some outfield this year.” Durbin hit .312 with five homers, 21 RBIs and 29 steals in 24 games at the Arizona Fall League. “We love the style of game that he brings to our team,” Arnold said. “I think that’s going to be a really nice fit with Pat Murphy's style of baseball.” Cashman said he's spoken with Scott Boras about the agent's remaining free agent clients, who include third baseman Alex Bregman and first baseman Pete Alonso. “Certainly respect the player and his ability and how much winning he’s been a part of,” Cashman said of Bregman, “but that’s about as far as I will say at this point.” This story has been corrected to note New York is sending cash to Milwaukee, not the other way around. AP MLB: https://apnews.com/hub/mlb
A MAJOR car brand has revealed it will be relaunching an iconic motor 18 years after production stopped - leaving eager shoppers thrilled. Toyota finally confirmed the return of the iconic Celica at the weekend, following years of speculation. It follows reports that the Japanese manufacturer was considering relaunching the model as an electric car, according to Autocar. It was originally produced from 1970 until 2006 and was available in various different versions, from convertibles to liftbacks to notchbacks. Speaking at Rally Japan , the company's vice president Yuki Nakajima said: "We're making the Celica!" He added: "To be honest, there is no sign of it right now. Read more Motors News "However, there are many people within the company who are eagerly awaiting the Celica. "So... I wonder if it's okay to say this in a public forum, but we're doing the Celica!" Rumours of the possible return of the beloved car had ramped up over recent weeks, after a recent episode of Toyota's anime series, Grip, appeared to hint at a host of new models. They included the Celica Mk8, as well as the Supra Mk6, MR2, Mk4, GR86 Mk3 and GR GT3. Most read in Motors And, Toyota chairman Akio Toyoda has previously spoken of his wish to revive what he describes as "the three brothers" - the Celica, MR2 and Supra. The company has been working on a new electric car platform with a low seat height - making it feel like a sports car. The FT-Se concept, which was revealed at last year's motor show, will be used as the basis for a new model similar to the MR2. However, it is thought that it will not be called the MR2. The possibility of a next-generation Supra has not yet been spoken on publicly by the brand. However, the S-FR roadster concept is set to appear in showrooms soon, according to Japanese magazine Best Car. News of the revived Celica comes after car brand Lancia announced it would be relaunching its Gamma model - which was discontinued 40 years ago. The Gamma nameplate has a cult following among car fans, havig been the brand's executive offering from 1976 until it was discontinued in 1984. READ MORE SUN STORIES And, Jaguar unveiled a new logo as part of its electric re-brand. The luxury car manufacturer sparked a heated debate, with some claiming it looks like "it was designed by kids", while others "love it".
Samsung Electronics makes key leadership changes with focus on chip divisions; shares drop
Phillips 66 stock rises Monday, still underperforms marketRobinson scores 25 in Mercer's 90-89 OT win against Jacksonville
JOHANNESBURG South Africa on Monday reiterated its call for an immediate cease-fire in Palestine and Lebanon and the initiation of a political process to secure a just and lasting peace. "South Africa once again calls on the State of Israel to realize that the only way to achieve peace is a two-state solution where Israel will be able to exist side-by-side in peace with a viable and fully independent Palestinian State within internationally recognized parameters," said a statement marking the 47th United Nations International Day of Solidarity with the Palestinian People. Pretoria highlighted that the unresolved Palestinian issue, now spanning 75 years, remains central to tensions in the Middle East. "This occasion (International Day of Solidarity) provides us with a crucial opportunity to reflect and take stock of the plight of the people of Palestine," the statement said. South Africa reaffirmed its unwavering commitment to strengthening its bond of solidarity, friendship and cooperation with Palestine. "In keeping with South Africa’s long-term and principled support for the Palestinian people, the Government of South Africa remains committed to supporting initiatives aimed at refocusing the international agenda on Palestine and a revived Middle East peace process," the statement added. The government also urged the international community to intensify efforts to assist Palestinians in achieving their aspirations for freedom, justice and the establishment of an independent state.Three long days of counting in the General Election finished late on Monday night when the final two seats were declared in the constituency of Cavan-Monaghan. Fianna Fail was the clear winner of the election, securing 48 of the Dail parliament’s 174 seats. Sinn Fein took 39 and Fine Gael 38. Labour and the Social Democrats both won 11 seats; People Before Profit-Solidarity took three; Aontu secured two; and the Green Party retained only one of its 12 seats. Independents and others accounted for 21 seats. The return of a Fianna Fail/Fine Gael-led coalition is now highly likely. However, their combined seat total of 86 leaves them just short of the 88 needed for a majority in the Dail. While the two centrist parties that have dominated Irish politics for a century could look to strike a deal with one of the Dail’s smaller centre-left parties, such as the Social Democrats or Labour, a more straightforward route to a majority could be achieved by securing the support of several independent TDs. For Fianna Fail leader Micheal Martin and current taoiseach and Fine Gael leader Simon Harris, wooing like-minded independents would be likely to involve fewer policy concessions, and financial commitments, than would be required to convince another party to join the government benches. Longford-Westmeath independent TD Kevin “Boxer” Moran, who served in a Fine Gael-led minority government between 2017 and 2020, expressed his willingness to listen to offers to join the new coalition in Dublin. “Look, my door’s open,” he told RTE. “Someone knocks, I’m always there to open it.” Marian Harkin, an independent TD for Sligo-Leitrim, expressed her desire to participate in government as she noted that Fianna Fail and Fine Gael were within “shouting distance” of an overall majority. “That means they will be looking for support, and I certainly will be one of those people who will be speaking to them and talking to them and negotiating with them, and I’m looking forward to doing that, because that was the reason that I ran in the first place,” she said. Meanwhile, the Social Democrats and Irish Labour Party both appear cautious about the prospect of an alliance with Fianna Fail and Fine Gael. They will no doubt be mindful of the experience of the Green Party, the junior partner in the last mandate. The Greens experienced near wipeout in the election, retaining only one of their 12 seats. Sinn Fein appears to currently have no realistic route to government, given Fianna Fail and Fine Gael’s ongoing refusal to share power with the party. Despite the odds being stacked against her party, Sinn Fein president Mary Lou McDonald contacted the leaders of the Social Democrats and Labour on Monday to discuss options. Earlier, Fianna Fail deputy leader and outgoing Finance Minister Jack Chambers predicted that a new coalition government would not be in place before Christmas. Mr Chambers said planned talks about forming an administration required “time and space” to ensure that any new government will be “coherent and stable”. After an inconclusive outcome to the 2020 election, it took five months for Fianna Fail, Fine Gael and the Greens to strike the last coalition deal. Mr Chambers said he did not believe it would take that long this time, as he noted the Covid-19 pandemic was a factor in 2020, but he also made clear it would not be a swift process. He said he agreed with analysis that there was no prospect of a deal before Christmas. “I don’t expect a government to be formed in mid-December, when the Dail is due to meet on December 18, probably a Ceann Comhairle (speaker) can be elected, and there’ll have to be time and space taken to make sure we can form a coherent, stable government,” he told RTE. “I don’t think it should take five months like it did the last time – Covid obviously complicated that. But I think all political parties need to take the time to see what’s possible and try and form a stable government for the Irish people.” Fine Gael minister of state Peter Burke said members of his parliamentary party would have to meet to consider their options before giving Mr Harris a mandate to negotiate a new programme for government with Fianna Fail. “It’s important that we have a strong, stable, viable government, whatever form that may be, to ensure that we can meet the challenges of our society, meet the challenges in terms of the economic changes that are potentially going to happen,” he told RTE. Despite being set to emerge with the most seats, it has not been all good news for Fianna Fail. The party’s outgoing Health Minister Stephen Donnelly became one of the biggest casualties of the election when he lost his seat in Wicklow in the early hours of Monday morning. Mr Donnelly was always predicted to face a fight in the constituency after boundary changes saw it reduced from five to four seats. If it is to be a reprise of the Fianna Fail/Fine Gael governing partnership of the last mandate, one of the major questions is around the position of taoiseach and whether the parties will once again take turns to hold the Irish premiership during the lifetime of the new government. The outcome in 2020 saw the parties enter a coalition on the basis that the holder of the premier position would be exchanged midway through the term. Fianna Fail leader Mr Martin took the role for the first half of the mandate, with Leo Varadkar taking over in December 2022. Current Fine Gael leader Mr Harris succeeded Mr Varadkar as taoiseach when he resigned from the role earlier this year. However, this time Fianna Fail has significantly increased its seat lead over Fine Gael, compared with the last election when there were only three seats between the parties. The size of the disparity in party numbers is likely to draw focus on the rotating taoiseach arrangement, raising questions as to whether it will be re-run in the next coalition and, if it is, on what terms. On Sunday, Simon Coveney, a former deputy leader of Fine Gael, said a coalition that did not repeat the rotating taoiseach arrangement in some fashion would be a “difficult proposition” for his party. Meanwhile, Fine Gael minister Paschal Donohoe said he would be making the case for Mr Harris to have another opportunity to serve as taoiseach. On Monday, Mr Chambers said while his party would expect to lead the government it would approach the issue of rotating the taoiseach’s role on the basis of “mutual respect” with Fine Gael. “I think the context of discussions and negotiations will be driven by mutual respect, and that’s the glue that will drive a programme for government and that’s the context in which we’ll engage,” he said. On Monday, Labour leader Ivana Bacik reiterated her party’s determination to forge an alliance with fellow centre-left parties with the intention of having a unified approach to the prospect of entering government. Asked if Labour was prepared to go into government with Fianna Fail and Fine Gael on its own, she told RTE: “No, not at this stage. We are absolutely not willing to do that. “We want to ensure there’s the largest number of TDs who share our vision and our values who want to deliver change on the same basis that we do.” The Social Democrats have been non-committal about any potential arrangement with Fianna Fail and Fine Gael, and have restated a series of red lines they would need to achieve before considering taking a place in government. Leader Holly Cairns, who gave birth to a daughter on polling day on Friday, said in a statement: “The party is in a very strong position to play an important role in the next Dail. In what position, government or opposition, remains to be seen.” Fianna Fail secured the most first preference votes in Friday’s proportional representation election, taking 21.9% to Fine Gael’s 20.8%. Sinn Fein came in third on 19%. While Sinn Fein’s vote share represented a marked improvement on its disappointing showing in June’s local elections in Ireland, it is still significantly down on the 24.5% poll-topping share it secured in the 2020 general election. The final breakdown of first preferences also flipped the result of Friday night’s exit poll, which suggested Sinn Fein was in front on 21.1%, with Fine Gael on 21% and Fianna Fail on 19.5%.
MANILA – Gilas Pilipinas moved closer to the FIBA Asia Cup 2025 following a 93-54 rout of Hong Kong, witnessed by 11,896 fans at Mall of Asia Arena in Pasay City on Sunday night, November 24, 2024. Gilas Pilipinas took the lead early although it wasn’t until the third quarter where it broke the game wide open, eventually extending its unbeaten streak to four to stay atop Group B, highlighted by a 93-89 upset of World No. 22 New Zealand on Thursday. Gilas also whipped Hong Kong, 84-64, and Chinese Taipei, 106-53, in February. READ MORE : Froilan Maglasang crowned CESAFI’s 3-point king If New Zealand (2-1) beats Chinese Taipei (1-2) in Christchurch on Monday, Gilas will formalize its trip to the Saudi Arabia Cup in August next year. Carl Tamayo topscored for the Filipinos with 18 points on 8-of-15 shooting from the field and grabbed 6 rebounds as he made the most out of coach Tim Cone’s decision to give the younger ones extended playing time. Veteran June Mar Fajardo finished with 14 points and 8 rebounds, while Justin Brownlee supplied 13 points, 3 rebounds, 3 assists, and 3 steals Kai Sotto tallied 12 points and 15 rebounds with 2 assists and the same amount of blocks as he continued his solid play after starring versus the Tall Blacks. Scottie Thompson was crucial in the third-quarter pullaway, forming a three-headed attack along with Brownlee and Fajardo to put together the 13-0 run en route to a commanding 67-40 lead with 1:05 remaining in the period. “In the second half, I felt that we came out and we got to the shooters a little bit better. We scrambled a little bit more. We should get out there because we’ve got protection behind us in June Mar and Kai,” Cone said.
THOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday , Dec. 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, Jay Bradner , executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney , executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2024-global-healthcare-conference-302319891.html SOURCE AmgenNEW YORK — For about 50 years, adding cavity-preventing fluoride to drinking water was a popular public health measure in Yorktown, a leafy town north of New York City. But in September, the town’s supervisor used his emergency powers to stop the practice. The reason? A recent federal judge’s decision that ordered U.S. regulators to consider the risk that fluoride in water could cause lower IQ in kids. “It’s too dangerous to look at and just say ‘Ah, screw it. We’ll keep going on,’” said the town supervisor, Ed Lachterman. Yorktown isn’t alone. The decision to add fluoride to drinking water rests with state and local officials, and fights are cropping up nationwide. Communities in Florida, Texas, Oregon, Utah, Wyoming and elsewhere have debated the idea in recent months — the total number is in the dozens, with several deciding to stop adding it to drinking water, according to Fluoride Action Network, an advocacy organization against water fluoridation. In Arkansas, legislators this week filed a bill to repeal the state’s fluoridation program. The debates have been ignited or fueled by three developments: —In August, a federal agency reported “with moderate confidence” that there is a link between high levels of fluoride exposure — more than twice the recommended limit — and lower IQ in kids. —In September, the federal judge ordered the U.S. Environmental Protection Agency to further regulate fluoride in drinking water because high levels could pose a risk to the intellectual development of children. —This month, just days before the election, Robert F. Kennedy Jr. declared that Donald Trump would push to remove fluoride from drinking water on his first day as president. Trump later picked Kennedy to run the Department of Health and Human Services. In Durango, Colorado, there was an unsuccessful attempt to stop fluoridating the water during Trump’s first term in office. A new push came this year, as Trump saw a surge of political support. “It’s just kind of the ebb and flow of politics on the national level that ultimately affects us down here,” said city spokesman Tom Sluis. Fluoride strengthens teeth and reduces cavities by replacing minerals lost during normal wear and tear , according to the U.S. Centers for Disease Control and Prevention. In 1950, federal officials endorsed water fluoridation to prevent tooth decay, and the addition of low levels of fluoride to drinking water has long been considered one of the greatest public health achievements of the last century. Fluoride can come from a number of sources, but drinking water is the main source for Americans, researchers say. Nearly two-thirds of the U.S. population gets fluoridated drinking water , according to CDC data. There is a recommended fluoridation level, but many communities exceed that, sometimes because fluoride occurs naturally at higher levels in certain water sources. Opposition is nothing new, though for decades it was considered a fringe opinion. Adherents included conspiracy theorists who claimed fluoridation was a plot to make people submissive to government power. Health officials could point to studies that showed that cavities were less common in communities with fluoridated water, and that dental health worsened in communities without it. But fluoride isn't just in water. Through the years it became common in toothpaste, mouthwash and other products. And data began to emerge that there could be too much of a good thing: In 2011, officials reported that 2 out of 5 U.S. adolescents had at least mild tooth streaking or spottiness because of too much fluoride. In 2015, the CDC recommended that communities revisit how much they were putting in the water. Beginning in 1962, the government recommended a range of 0.7 milligrams per liter for warmer climates where people drink more water to 1.2 milligrams in cooler areas. The new standard became 0.7 everywhere. Over time, more studies pointed to a different problem: a link between higher levels of fluoride and brain development. The August report by the federal government’s National Toxicology Program — summarizing studies conducted in Canada, China, India, Iran, Pakistan and Mexico — concluded that drinking water containing more than 1.5 milligrams of fluoride per liter was associated with lower IQs in kids. “There’s no question that fluoride prevents cavities,” said Dr. Tom Frieden, who was director of the CDC when the agency changed the recommended fluoride levels. “There’s also no question we’re getting more fluoride than we were 50 years ago, through toothpaste and other things.” Frieden said “a legitimate question” has been raised about whether fluoride affects brain development, and studies making that link “need to be looked at carefully.” Many people in health care strongly embrace water fluoridation. The American Dental Association and the American Academy of Pediatrics reaffirmed their endorsement of current CDC recommendations in the wake of the federal report and the judge’s ruling. Colorado’s health department, which weighed in during a Nov. 5 Durango city council meeting, said in a statement that it “seeks to align its public health recommendations with the latest scientific research. The facts of this court ruling are not sufficient” to revise current fluoridation levels. Durango officials are waiting to see what the EPA does in reaction to the recent court decision, said Sluis, the city spokesman. “We follow the science,” he said. “It wouldn’t be in the best interest of the city to stop fluoridation based on one judge’s interpretation.” In Yorktown, Lachterman concluded the judge’s decision was enough to halt fluoridation. He recalled a community discussion several years ago in which most people in the room clearly favored fluoridation, but recently it seems public comment has reversed. “It’s like a total 180,” he said. But not all public pressure these days is against the idea. In September, Buffalo, New York, announced it would resume water fluoridation after not having it for nearly a decade. News reports had described an increase in tooth decay and families sued, seeking damages for dental costs. The Buffalo Sewer Authority’s general manager, Oluwole McFoy declined to discuss the decision with The Associated Press, citing the litigation. For its part, the EPA “is in the process of reviewing the district court’s decision,” spokesman Jeff Landis said this week. In Monroe, Wisconsin, fluoridation “has become a very hot issue,” said its mayor, Donna Douglas. The small city, near Madison, started fluoridating its drinking water in the early 1960s. But in the late summer, some residents began calling and emailing Douglas, saying she needed to do something about what they saw as a public health danger. The first call “was more like a threat,” she recalled. Douglas said she did not take a position on whether to stop, but decided to raise it to the city council for discussion. The discussions were unusually emotional. Few people tend to speak during public comment sessions at council meetings, said Douglas. But more than two dozen people spoke at a city council meeting last month, most of them in favor of fluoridation. At a subsequent meeting, about a dozen more people — all opposed to fluoridation — came out to speak. “This is the first time we’ve had any debates at all” like this, Douglas said. “I didn’t realize it would be such a heated discussion.” ___ AP video journalist Brittany Peterson and AP reporter Andrew DeMillo contributed to this report. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Daphnila Vis: From Mrs. Grand Queen Universe 2022 to Prominent Beauty Advocate in Dubai 11-25-2024 11:02 PM CET | Fashion, Lifestyle, Trends Press release from: Getnews / PR Agency: Internet Marketing Company Image: https://www.getnews.info/wp-content/uploads/2024/11/1732343573.jpeg Daphnila Vis Photo Daphnila Vis, Mrs. Grand Queen Universe 2022, empowers women through beauty expertise and the Pink Girls Club Dubai, promoting confidence and personal growth. Daphnila Vis, crowned Mrs. Grand Queen Universe 2022 [ https://www.instagram.com/daphnila/?igsh=azlyc3NwOTBlb2Rq ], has transformed from a beauty queen to a powerful beauty influencer in Dubai. Known for her expertise in skincare, fashion, and women's empowerment, Daphnila has built a platform that inspires confidence and supports women worldwide. From Passion to Expertise Daphnila's love for beauty began long before she was crowned Mrs. Grand Queen Universe 2022. As a certified skincare therapist with a KHDA license, she established herself as a trusted beauty expert in Dubai. Collaborating with renowned international beauty brands, she delivers professional skincare advice and solutions, seamlessly blending her passion for the industry with the latest trends. Mrs. Grand Queen Universe 2022: A Pivotal Achievement Winning Mrs. Grand Queen Universe 2022 was a turning point for Daphnila. The title represented not only her beauty but also her dedication to empowering women. Her reign embodied elegance and confidence, paving the way for her to become a role model and advocate for self-care and empowerment. Beauty With A Purpose: A Blog That Inspires Following her pageant success, Daphnila launched Beauty With A Purpose, a blog dedicated to sharing skincare tips, beauty hacks, and product recommendations. The blog celebrates beauty as an expression of self-confidence and wellness, connecting with readers who seek empowerment through their daily routines. Through her professional advice and purpose-driven content, Daphnila has become a trusted voice in the beauty industry. Empowering Women: The Pink Girls Club Dubai As an extension of her commitment to women's empowerment, Daphnila founded the Pink Girls Club Dubai [ https://www.instagram.com/daphnila/?igsh=azlyc3NwOTBlb2Rq ], a members-only community fostering personal and professional growth. The club connects women through networking events and workshops, offering a supportive environment to grow, collaborate, and achieve their dreams. This initiative highlights Daphnila's dedication to creating spaces where women can thrive together. A Growing Influence Daphnila's influence continues to grow through high-profile events, collaborations with leading brands, and a thriving online presence. Her authenticity and expertise in beauty and empowerment have attracted a global audience. As a digital influencer, she remains a beacon of confidence, inspiring others to prioritize wellness and self-care. A Vision for the Future Looking ahead, Daphnila is committed to evolving as a beauty advocate and empowerment influencer. Her work goes beyond aesthetics, emphasizing wellness, confidence, and self-care through her blog, social media, and public appearances. As she expands her initiatives, Daphnila invites women worldwide to join her in creating a more empowered future. Media Contact Company Name: Daphnila Contact Person: Daphnila Vis Email: Send Email [ http://www.universalpressrelease.com/?pr=daphnila-vis-from-mrs-grand-queen-universe-2022-to-prominent-beauty-advocate-in-dubai ] City: Los Angeles State: California Country: United States Website: https://www.instagram.com/daphnila?igsh=azlyc3NwOTBlb2Rq This release was published on openPR.Qatar tribune agencies Manila An impeachment complaint was filed on Monday against Philippine Vice President Sara Duterte on allegations of corruption, breach of public trust and other constitutional violations. The complaint - the first against a vice president in the Philippines - was filed in the House of Representatives by a group of civil society leaders, former government officials and sectoral representatives, including a family member of a victim of the controversial war on drugs unleashed by the vice president’s father, former president Rodrigo Duterte. “The vice president has reduced public office to a platform for violent rhetoric, personal enrichment, elitist entitlement and a shield for impunity,” said Teresita Quintos Deles, a former government official and one of the complainants. “Her actions desecrate our institutions, and her continued grip on power insults every Filipino who stands for good governance and the rule of law,” she added. The complaint was endorsed by left-wing Akbayan party representative Perci Cendeña, who said: “We cannot allow public office to be weaponized for corruption, violence and betrayal of trust. The Filipino people deserve leaders who serve with integrity, not rulers who exploit power for personal gain.” Duterte did not immediately issue any response to the impeachment bid, which accused her of about two dozen alleged crimes. The impeachment complaint was filed more than one week after Duterte threatened to have President Ferdinand Marcos Jr, the first lady and the House speaker assassinated if she herself was killed. The threat came amid an investigation on the alleged misuse of 612.5 million pesos ($10.4 million) worth of funds of the Department of Education. Vice President Duterte resigned from her post as education secretary in Marcos’ Cabinet in June, indicating a crack in the political alliance that propelled the duo to a clear victory in 2022. The impeachment complaint will be scrutinized by the Philippine Congress, which is dominated by allies of Marcos and his cousin and key backer, Romualdez, who also has been politically at odds with the vice president. Copy 03/12/2024 10